Tamer I. Khayal - 03 Mar 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Reporting relationship: Chief Commercial Officer
Issuer ticker: TMDX
Reported as of: 03 Mar 2025
Net transaction value: -$183,967
SEC form: 4
Accepted by SEC: 05 Mar 2025, 16:30:17 UTC
Prior SEC filing: 26 Feb 2025
Source filing: View source filing
Reporting owner signature: By: /s/ Gerardo Hernandez, Attorney-in-Fact

Key filing fact

Tamer I. Khayal filed Form 4 for TransMedics Group, Inc. (TMDX) on 05 Mar 2025.

Key facts

This page summarizes Tamer I. Khayal's Form 4 filing for TransMedics Group, Inc. (TMDX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Mar 2025, 16:30.

Change

Previous filing in this sequence was filed on 26 Feb 2025.
Current net transaction value: -$183,967.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMDX transaction

Common Stock

Sale

Transaction value: $183,967
Shares: -2,407
Change %: -6.3%
Price: $76.43
Shares after: 36,042
Date: 03 Mar 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.